ID: ALA4648110

Max Phase: Preclinical

Molecular Formula: C34H53NO2

Molecular Weight: 507.80

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@H](CCCNCc1ccccc1)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C

Standard InChI:  InChI=1S/C34H53NO2/c1-23(11-10-20-35-22-24-12-8-7-9-13-24)25-18-19-32(4)28-16-14-26-27(15-17-29(36)31(26,2)3)34(28,6)30(37)21-33(25,32)5/h7-9,12-14,23,25,27-30,35-37H,10-11,15-22H2,1-6H3/t23-,25-,27-,28+,29+,30-,32+,33-,34+/m1/s1

Standard InChI Key:  JAMPNBVMBIYBGJ-JFAMYKFUSA-N

Associated Targets(Human)

AMPK alpha2/beta1/gamma1 210 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 507.80Molecular Weight (Monoisotopic): 507.4076AlogP: 7.13#Rotatable Bonds: 7
Polar Surface Area: 52.49Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 2HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.64CX LogP: 6.36CX LogD: 4.16
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: 2.27

References

1. Wang J, Liu J, Xie Z, Li J, Li J, Hu L..  (2020)  Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators.,  30  (2): [PMID:31744674] [10.1016/j.bmcl.2019.126790]

Source